(Q37690306)

English

Efficacy, safety and population pharmacokinetics of sapropterin in PKU patients <4 years: results from the SPARK open-label, multicentre, randomized phase IIIb trial

scientific article published on 09 March 2017

Statements

Efficacy, safety and population pharmacokinetics of sapropterin in PKU patients <4 years: results from the SPARK open-label, multicentre, randomized phase IIIb trial (English)
Ania C Muntau
Alberto Burlina
François Eyskens
Peter Freisinger
Corinne De Laet
Vincenzo Leuzzi
Frank Rutsch
H Serap Sivri
Suresh Vijay
Milva Orquidea Bal
Gwendolyn Gramer
Renata Pazdírková
Maureen Cleary
Amelie S Lotz-Havla
Alain Munafo
Diane R Mould
Flavie Moreau-Stucker
Daniela Rogoff
9 March 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit